Identification of key genes and construction of microRNA-mRNA regulatory networks in non-small cell lung cancer

Vergnenègre, 2018, Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC), Expert Rev Pharmacoecon Outcomes Res, 18, 519, 10.1080/14737167.2018.1485099 Siegel, 2018, Cancer statistics, 2018, CA Cancer J Clin, 68, 7, 10.3322/caac.21442 Maemondo, 2010, Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR, N Engl J Med, 362, 2380, 10.1056/NEJMoa0909530 Cho, 2010, MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy, Int J Biochem Cell Biol, 42, 1273, 10.1016/j.biocel.2009.12.014 Loginov, 2018, Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis, Gene, 662, 28, 10.1016/j.gene.2018.04.005 Yan, 2018, MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer, J Cell Physiol, 233, 6660, 10.1002/jcp.26316 Yanaihara, 2006, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, 9, 189, 10.1016/j.ccr.2006.01.025 Iorio, 2012, Causes and consequences of microRNA dysregulation, Cancer J, 18, 215, 10.1097/PPO.0b013e318250c001 Barrett, 2006, Gene expression omnibus: microarray data storage, submission, retrieval, and analysis, Methods Enzymol, 411, 352, 10.1016/S0076-6879(06)11019-8 Jang, 2012, Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers, Clin Cancer Res, 18, 3658, 10.1158/1078-0432.CCR-11-2857 Luo, 2018, Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation, World J Surg Oncol, 16, 76, 10.1186/s12957-018-1378-6 Gautier, 2004, affy–analysis of affymetrix GeneChip data at the probe level, Bioinformatics, 20, 307, 10.1093/bioinformatics/btg405 Wettenhall, 2004, limmaGUI: a graphical user interface for linear modeling of microarray data, Bioinformatics, 20, 3705, 10.1093/bioinformatics/bth449 Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R S Soc Ser B (Methodol), 57, 289 Dweep, 2014, miRWalk database for miRNA-target interactions, Methods Mol Biol, 1182, 289, 10.1007/978-1-4939-1062-5_25 Kozomara, 2014, miRBase: annotating high confidence microRNAs using deep sequencing data, Nucleic Acids Res, 42, D68, 10.1093/nar/gkt1181 Wang, 2008, miRDB: a microRNA target prediction and functional annotation database with a wiki interface, RNA, 14, 1012, 10.1261/rna.965408 Hsu, 2011, miRTarBase: a database curates experimentally validated microRNA-target interactions, Nucleic Acids Res, 39, D163, 10.1093/nar/gkq1107 Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, OMICS, 16, 284, 10.1089/omi.2011.0118 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci USA, 102, 15545, 10.1073/pnas.0506580102 Doerge, 1996, Permutation tests for multiple loci affecting a quantitative character, Genetics, 142, 285, 10.1093/genetics/142.1.285 Csárdi, 2010, Modular analysis of gene expression data with R, Bioinformatics, 26, 1376, 10.1093/bioinformatics/btq130 Chen, 2016, Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer, Tumour Biol, 37, 11927, 10.1007/s13277-016-5052-8 Wang, 2011, MicroRNA-206 is associated with invasion and metastasis of lung cancer, Anat Rec, 294, 88, 10.1002/ar.21287 Zhang, 2011, Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression, Anticancer Res, 31, 3859 Ni, 2015, Epithelial mesenchymal transition of non-small-cell lung cancer cells A549 induced by SPHK1, Asian Pac J Trop Med, 8, 142, 10.1016/S1995-7645(14)60305-9 Xiao, 2010, Epithelial mesenchymal transition and lung cancer, J Thorac Dis, 2, 154 Wang, 2014, Associations between hsa-miR-603 polymorphism, lifestyle-related factors and colorectal cancer risk, Cancer Biomark, 14, 225, 10.3233/CBM-140395 Knudsen, 2006, Cyclin D1: polymorphism, aberrant splicing and cancer risk, Oncogene, 25, 1620, 10.1038/sj.onc.1209371 Musgrove, 2011, Cyclin D as a therapeutic target in cancer, Nat Rev Cancer, 11, 558, 10.1038/nrc3090 Dragoj, 2015, Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients' outcome, Tumour Biol, 36, 8773, 10.1007/s13277-015-3620-y Yang, 2015, PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells, Int J Cancer, 136, E39, 10.1002/ijc.29150 Sun, 2013, Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer, J Biomed Res, 27, 220 Mihaylova, 2011, The AMPK signalling pathway coordinates cell growth, autophagy and metabolism, Nat Cell Biol, 13, 1016, 10.1038/ncb2329